{"title": "PREVNAR\u00ae 13 Quick Finder", "author": null, "url": "https://www.pfizermedicalinformation.com/en-us/prevnar-13/highlights", "hostname": "pfizermedicalinformation.com", "description": "HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PREVNAR 13 safely and effectively. See full prescribing information for PREVNAR 13. PREVNAR 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria", "sitename": "pfizermedicalinformation.com", "date": "2019-07-01", "cleaned_text": "HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PREVNAR 13 safely and effectively. See full prescribing information for intramuscular injection Initial U.S. Approval: 2010 INDICATIONS AND USAGE In children 6 weeks through 5 years of age (prior to the 6th birthday), Prevnar 13 is indicated for: In children 6 years through 17 years of age (prior to the 18th birthday), Prevnar 13 is indicated for: In adults 18 years of age and older, Prevnar 13 is indicated for: Limitations of Prevnar 13 Use and Effectiveness DOSAGE AND ADMINISTRATION DOSAGE FORMS AND STRENGTHS 0.5 mL suspension for intramuscular injection, supplied in a single-dose prefilled syringe. ( CONTRAINDICATIONS Severe allergic reaction (e.g., anaphylaxis) to any component of Prevnar 13 or any diphtheria toxoid-containing vaccine. ( WARNINGS AND PRECAUTIONS Apnea following intramuscular vaccination has been observed in some infants born prematurely. Decisions about when to administer an intramuscular vaccine, including Prevnar 13, to infants born prematurely should be based on consideration of the individual infant's medical status, and the potential benefits and possible risks of vaccination. ( ADVERSE REACTIONS To report SUSPECTED ADVERSE REACTIONS, contact Wyeth Pharmaceuticals LLC. at 1-800-438-1985 or VAERS at 1-800-822-7967 or http://vaers.hhs.gov. USE IN SPECIFIC POPULATIONS Pediatric Use: Safety and effectiveness of Prevnar 13 in children below the age of 6 weeks have not been established. ( See 17 for PATIENT COUNSELING INFORMATION. Revised: 7/2019 If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents. PREVNAR\u00ae 13 Highlights (pneumococcal 13-valent conjugate vaccine - diphtheria CRM197 protein) Resources Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine. *Contact Medical Information. Submit a medical question for Pfizer prescription products. To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this product, click the link below to submit your information: [Pfizer Safety Reporting Site](https://www.pfizersafetyreporting.com/) *If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site. If you cannot use the above website to report an adverse event related to a Pfizer product, please call Pfizer Medical Information at [(800) "}